CGRP therapy in primary care for migraine: prevention and acute medication.
作者信息
Phillips Katherine, Wakerley Benjamin R
机构信息
NIHR clinical lecturer in public health, Institute of Applied Health Research, University of Birmingham, Birmingham.
Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham; Metabolic Neurology, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, the Medical School, University of Birmingham, Birmingham.
出版信息
Br J Gen Pract. 2024 Oct 31;74(748):521-522. doi: 10.3399/bjgp24X739893. Print 2024 Nov.
Abstract
摘要
相似文献
1
CGRP therapy in primary care for migraine: prevention and acute medication.基层医疗中用于偏头痛的降钙素基因相关肽（CGRP）疗法：预防与急性用药
Br J Gen Pract. 2024 Oct 31;74(748):521-522. doi: 10.3399/bjgp24X739893. Print 2024 Nov.
2
Chronification of migraine sensitizes to CGRP in male and female mice.偏头痛的慢性化使雄性和雌性小鼠对降钙素基因相关肽（CGRP）敏感。
Cephalalgia. 2025 Feb;45(2):3331024251317446. doi: 10.1177/03331024251317446.
3
Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review.抗 CGRP 单克隆抗体治疗耐药性慢性偏头痛：系统评价。
Eur J Med Res. 2022 Jun 4;27(1):86. doi: 10.1186/s40001-022-00716-w.
4
Comparative Efficacy and Safety of Five Anti-calcitonin Gene-related Peptide Agents for Migraine Prevention: A Network Meta-analysis.五种抗降钙素基因相关肽药物预防偏头痛的疗效和安全性比较：网络荟萃分析。
Clin J Pain. 2023 Oct 1;39(10):560-569. doi: 10.1097/AJP.0000000000001136.
5
Noninvasive Vagus Nerve Stimulation for Cluster Headache and Migraine: A Health Technology Assessment.用于丛集性头痛和偏头痛的非侵入性迷走神经刺激：一项卫生技术评估
Ont Health Technol Assess Ser. 2025 May 1;25(2):1-177. eCollection 2025.
6
Effectiveness and safety of anti-CGRP monoclonal antibodies for migraine in patients over 65 years: a systematic review.65岁以上偏头痛患者使用抗降钙素基因相关肽单克隆抗体的有效性和安全性：一项系统评价
Pain Manag. 2025 Mar;15(3):161-171. doi: 10.1080/17581869.2025.2470615. Epub 2025 Mar 3.
7
Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis.评估托吡酯、A型肉毒杆菌毒素和靶向降钙素基因相关肽的单克隆抗体治疗慢性偏头痛和药物过量使用性头痛患者的随机对照研究：一项系统评价和荟萃分析。
Cephalalgia. 2023 Apr;43(4):3331024231156922. doi: 10.1177/03331024231156922.
8
Evaluating the impact of anti-CGRP monoclonal antibodies on retinal features in migraine patients: a retrospective optical coherence tomography study.评估抗降钙素基因相关肽单克隆抗体对偏头痛患者视网膜特征的影响：一项回顾性光学相干断层扫描研究
Ther Adv Neurol Disord. 2025 Jun 24;18:17562864251347277. doi: 10.1177/17562864251347277. eCollection 2025.
9
Systemic calcitonin gene-related peptide modifies auditory and vestibular end organ electrical potentials, and increases sensory hypersensitivities.全身性降钙素基因相关肽可改变听觉和前庭终器的电位，并增加感觉超敏反应。
J Neurophysiol. 2025 Jul 1;134(1):107-117. doi: 10.1152/jn.00226.2024. Epub 2025 May 27.
10
Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis.针对既往预防性治疗失败的偏头痛患者，使用降钙素基因相关肽单克隆抗体或其受体的疗效和安全性：一项网络荟萃分析。
J Headache Pain. 2022 Sep 8;23(1):105. doi: 10.1186/s10194-022-01472-2.
本文引用的文献
1
CGRP-targeted medication in chronic migraine - systematic review.降钙素基因相关肽靶向药物治疗慢性偏头痛——系统评价。
J Headache Pain. 2024 Apr 5;25(1):51. doi: 10.1186/s10194-024-01753-y.
2
The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates.全球头痛患病率：更新报告，并分析方法学因素对患病率估计的影响。
J Headache Pain. 2022 Apr 12;23(1):34. doi: 10.1186/s10194-022-01402-2.
3
New Generation Gepants: Migraine Acute and Preventive Medications.新一代头痛裤：偏头痛急性和预防性药物。
J Clin Med. 2022 Mar 16;11(6):1656. doi: 10.3390/jcm11061656.
4
Migraine: epidemiology and systems of care.偏头痛：流行病学和照护体系。
Lancet. 2021 Apr 17;397(10283):1485-1495. doi: 10.1016/S0140-6736(20)32160-7. Epub 2021 Mar 25.
5
CGRP and its receptors provide new insights into migraine pathophysiology.降钙素基因相关肽及其受体为偏头痛发病机制提供新视角。
Nat Rev Neurol. 2010 Oct;6(10):573-82. doi: 10.1038/nrneurol.2010.127. Epub 2010 Sep 7.
Zotero 插件